生物技术与制药领域的最新动态
How Investors Are Reacting To Thermo Fisher Scientific (TMO) Product Launches and Strong Quarterly Results - simplywall.st
Thermo Fisher Scientific Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily
Illumina (ILMN) Soars 23.4% on Earnings Beat - Yahoo Finance
Waters Corporation (WAT) Q3 Earnings: What To Expect - Markets Financial Content
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario - MedCity News
Investors in Thermo Fisher Scientific (NYSE:TMO) have seen returns of 15% over the past three years - Yahoo Finance
Manifold Bio Announces Strategic Collaboration with Roche to Develop Multiple Next-Generation Brain Shuttles for Neurological Diseases - Business Wire
Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq
Illumina (ILMN) Returns to Profitability, Undervalued Versus Peers but Growth Lags Market - Yahoo Finance
Agilent Technologies (A): Evaluating Valuation as New CFO Adam Elinoff Joins to Drive Strategic Transformation - Yahoo Finance
Bones and Blood: Uncovering History Through DNA
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One - PharmTech.com
India rises to tenth place in Cytiva’s Global Biopharma Index 2025 - Express Pharma
'Hopeful' We'll Find Long-term Solution On China: Illumina CEO - Bloomberg.com
Illumina sales flat in Q3 amid China headwinds as CEO remains 'in dialogue' with agencies - Fierce Biotech
Why Illumina (ILMN) Stock Is Up Today - Yahoo Finance
Agilent selects Adam Elinoff as CFO - MedTech Dive
Thermo Fisher Scientific to Acquire Clario to Provide Deeper Clinical Insights - MedTech Intelligence
Thermo Fisher adds clinical trial tech outfit Clario to goodie bag in $9B deal - Fierce Biotech
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance